...
首页> 外文期刊>Human Pathology >GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics
【24h】

GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics

机译:GATA3作为与形态模拟的透明细胞乳头状肾细胞癌区分透明细胞乳头状肾细胞癌

获取原文
获取原文并翻译 | 示例

摘要

Summary Clear cell papillary renal cell carcinoma (CCPRCC) is a low-grade, indolent neoplasm with no reported cases of death from disease or metastasis. These lesions can show clinical, morphologic, and immunophenotypic overlap with several aggressive forms of renal cell carcinoma (RCC), including clear cell RCC, translocation RCC, and papillary RCC with cytoplasmic clearing. Given the difference in behavior, it is important to reliably separate these entities. We retrospectively reviewed 47 tumors from 45 patients with morphologic features of CCPRCC. All cases were stained against cytokeratin 7 (CK7), carbonic anhydrase IX (CAIX), and GATA3. Cases inconsistent with CCPRCC were reclassified. In addition, we stained tissue microarrays with 103 typical clear cell RCCs and 62 papillary RCCs, each in triplicate. Twenty-five cases were morphologically and immunophenotypically consistent with CCPRCC; all of them showed diffuse CK7 expression and cup-like reactivity with CAIX. Of these, 19 (76%) showed strong nuclear reactivity for GATA3. Although some non-CCPRCC neoplasms showed at least partial CK7/CAIX coexpression, none were immunopositive for GATA3. All background normal kidneys studied showed GATA3 expression in the distal tubules, collecting ducts, and retention cysts of the distal nephron. On follow-up, none of the patients with CCPRCC had recurrences or metastasis. Sensitivity and specificity for GATA3 staining in the diagnosis of CCPRCC were 76% and 100%, with positive and negative predictive values of 100% and 74%. In conclusion, GATA3 is specific and sensitive for CCPRCC and can be used for accurate distinction from its main mimickers. Coexpression of GATA3 and CK7 in most CCPRCC provides evidence of their origin from distal nephron. Highlights ? GATA3 immunoreactivity is present in 74% of clear cell papillary renal cell carcinomas (CCPRCC). ? None of the more aggressive morphologic mimics or CCPRCC showed immunoreactivity for GATA3. ? The sensitivity and specificity of GATA3 for diagnosing CCPRCC are 76% and 100%, respectively. ? GATA3 positivity in CCPRCC suggests a potential origin of this neoplasm in the distal nephron.
机译:发明内容透明细胞乳头状肾细胞癌(CCPRCC)是一种低级,惰性肿瘤,没有报告的疾病或转移死亡病例。这些病变可以显示临床,形态学和免疫型重叠,具有几种侵略性形式的肾细胞癌(RCC),包括具有细胞质清除的透明细胞RCC,易位RCC和乳头状rCC。鉴于行为的差异,重要的是可靠地分离这些实体。从CCPRCC的形态特征的45名患者回顾性地回顾了47例肿瘤。所有病例均针对细胞角蛋白7(CK7),碳酸酐酶IX(CAIX)和GATA3染色。与CCPRCC不一致的病例重新分类。此外,我们用103种典型的透明细胞RCC和62次乳头状菌体染色组织微阵列,每次染色32粒乳头癌。二十五个病例在形态上和免疫蛋白型与CCPRCC一致;所有这些都显示弥漫性CK7表达和杯状反应性与CAIX。其中,19(76%)显示了GATA3的强核反应性。尽管一些非CCPRCC肿瘤显示至少部分CK7 / CAIX共表达,但没有用于GATA3的免疫阳性。研究的所有背景正常肾脏在远端小管中显示出GATA3表达,收集管道和远端肾的保留囊肿。在随访时,CCPRCC的患者都没有复发或转移。 CCPRCC诊断中GATA3染色的敏感性和特异性为76%和100%,阳性和阴性预测值100%和74%。总之,GATA3对CCPRCC的特异性和敏感性,可用于从其主要模仿者的准确区分。大多数CCPRCC中GATA3和CK7的共同表达提供了从远端肾上的起源的证据。强调 ? GATA3免疫反应存在于74%的透明细胞乳头肾细胞癌(CCPRCC)中。还没有更具侵略性的形态模拟物或CCPRCC表明GATA3的免疫反应性。还诊断CCPRCC的GATA3的敏感性和特异性分别为76%和100%。还CCPRCC中的GATA3阳性表明该肿瘤在远端肾上的潜在来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号